Aura Biosciences Analyst Ratings
Aura Biosciences Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 07/27/2023 | 100.52% | Scotiabank | → $23 | Initiates Coverage On | → Sector Outperform |
| 03/16/2023 | 117.96% | JMP Securities | $30 → $25 | Maintains | Outperform |
| 11/11/2022 | 161.55% | JMP Securities | $26 → $30 | Maintains | Market Outperform |
| 07/19/2022 | 126.68% | JMP Securities | → $26 | Initiates Coverage On | → Market Outperform |
| 11/23/2021 | 231.3% | BTIG | → $38 | Initiates Coverage On | → Buy |
| 11/23/2021 | 205.14% | Evercore ISI Group | → $35 | Initiates Coverage On | → Outperform |
| 11/23/2021 | — | Cowen & Co. | Initiates Coverage On | → Outperform | |
| 11/23/2021 | 248.74% | SVB Leerink | → $40 | Initiates Coverage On | → Outperform |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 07/27/2023 | 100.52% | 加拿大丰业银行 | →$23 | 开始承保 | →板块跑赢大盘 |
| 03/16/2023 | 117.96% | JMP证券 | $30→$25 | 维护 | 跑赢大盘 |
| 2022年11月11日 | 161.55% | JMP证券 | $26→$30 | 维护 | 市场表现强于大盘 |
| 07/19/2022 | 126.68% | JMP证券 | →$26 | 开始承保 | →市场跑赢大盘 |
| 2021年11月23日 | 231.3% | BTIG | →$38 | 开始承保 | →购买 |
| 2021年11月23日 | 205.14% | Evercore ISI集团 | →$35 | 开始承保 | →跑赢大盘 |
| 2021年11月23日 | - | 考恩公司 | 开始承保 | →跑赢大盘 | |
| 2021年11月23日 | 248.74% | SVB Leerink | →$40 | 开始承保 | →跑赢大盘 |
What is the target price for Aura Biosciences (AURA)?
Aura Biosciences(AURA)的目标价是多少？
The latest price target for Aura Biosciences (NASDAQ: AURA) was reported by Scotiabank on July 27, 2023. The analyst firm set a price target for $23.00 expecting AURA to rise to within 12 months (a possible 100.52% upside). 3 analyst firms have reported ratings in the last year.
加拿大丰业银行于2023年7月27日报道了Aura Biosciences(纳斯达克：AURA)的最新目标价。这家分析公司将目标价定为2300美元，预计AURA将在12个月内升至(可能上涨100.52)。3家分析公司在过去一年公布了评级。
What is the most recent analyst rating for Aura Biosciences (AURA)?
Aura Biosciences(AURA)的最新分析师评级是多少？
The latest analyst rating for Aura Biosciences (NASDAQ: AURA) was provided by Scotiabank, and Aura Biosciences initiated their sector outperform rating.
纳斯达克的最新分析师评级是由加拿大丰业银行提供的，Aura Biosciences发起了其行业表现优于大盘的评级。
When is the next analyst rating going to be posted or updated for Aura Biosciences (AURA)?
Aura Biosciences(AURA)的下一次分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aura Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aura Biosciences was filed on July 27, 2023 so you should expect the next rating to be made available sometime around July 27, 2024.
分析师在进行了广泛的研究后得出股票评级，其中包括查阅公开财务报表，与Aura Biosciences的高管和客户交谈，以及听取收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。Aura Biosciences的上一次评级是在2023年7月27日提交的，所以你应该预计下一次评级将在2024年7月27日左右的某个时候提供。
Is the Analyst Rating Aura Biosciences (AURA) correct?
分析师对Aura Biosciences(AURA)的评级正确吗？
While ratings are subjective and will change, the latest Aura Biosciences (AURA) rating was a initiated with a price target of $0.00 to $23.00. The current price Aura Biosciences (AURA) is trading at is $11.47, which is within the analyst's predicted range.
虽然评级是主观的，并将发生变化，但最新的Aura生物科学(AURA)评级是以0.00美元至23.00美元的目标价启动的。目前Aura Biosciences(AURA)的交易价格为11.47美元，在分析师的预测范围内。